NCT06182202

Brief Summary

Lower limb amputees rely on their prosthetic to remain active and lead an independent life. In recent years, measuring residual muscle activity has been used to interpret a user's intent and thereby modulate prosthesis control. However, little knowledge is held on how residual muscle activity differs from non-amputated muscle. The research team will analyze and compare neuromuscular physiology in non-amputee individuals and amputees' non-amputated and residual muscles across functional tasks to better understand how amputees control their muscles. Such information will inform design of modern prosthesis controllers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 17, 2022

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2022

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

December 26, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

December 26, 2023

Status Verified

December 1, 2023

Enrollment Period

2.5 years

First QC Date

July 8, 2022

Last Update Submit

December 19, 2023

Conditions

Keywords

AmputeesElectromyographyUltrasoundNeuromuscular PhysiologyProsthesesMuscle Activation

Outcome Measures

Primary Outcomes (2)

  • Motor Unit Action Potential Amplitudes

    The investigators will measure muscle activity via electromyography on the individuals' muscles controlling their ankle joint (note for residual muscle they are controlling their phantom limb). Properties of motor units will be gathered from surface electromyography (EMG) decomposed into individual motor unit firings. These properties will be compared between intact and residual muscle.

    Through study completion (an average of 36 months).

  • Motor Unit Coherence

    The investigators will measure muscle activity via electromyography on the individuals' muscles controlling their ankle joint (note for residual muscle they are controlling their phantom limb). Properties of motor units will be gathered from surface electromyography (EMG) decomposed into individual motor unit firings. These properties will be compared between intact and residual muscle.

    Through study completion (an average of 36 months).

Secondary Outcomes (1)

  • Muscle Architecture Properties -- Muscle Volume

    Through study completion (an average of 36 months).

Study Arms (2)

Individuals Without Amputation

NO INTERVENTION

No Intervention Tested in identical tasks for comparison to Individuals with Amputation

Individuals With Amputation

EXPERIMENTAL

Tasks with a passive prosthesis Tasks with a powered active prosthesis

Device: Powered Prosthesis

Interventions

Custom in-house powered prosthetic device (used in prior studies, see Citations).

Individuals With Amputation

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Live in the United States
  • Are 18 years of age or older
  • Can walk across low-level environmental barriers such as curbs, stairs, or uneven surfaces unassisted and without much difficulty

You may not qualify if:

  • \- Have any cognitive, visual, or balance impairments that affects your ability to provide informed consent or to follow instructions during the experiments
  • Have had a stroke
  • Have heart disease
  • Weigh 450 pounds or more (for harness safety)
  • Have a girth/waist circumference more than 49 inches (124.4 cm) (for harness safety)
  • Have allergies to adhesives
  • Live in the United States
  • Are a unilateral lower-limb amputee
  • Have lower limb length from the knee to where the amputation occurred at least 10cm long
  • Can walk across low-level environmental barriers such as curbs, stairs, or uneven surfaces unassisted and without much difficulty
  • \- Have any cognitive, visual, or balance impairments that affects your ability to provide consent or to follow instructions during the experiments
  • Have had a stroke
  • Have heart disease
  • Had skin lesions/incomplete healing following amputation
  • Have ulcers
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Carolina State University

Raleigh, North Carolina, 27695, United States

RECRUITING

Related Publications (1)

  • Huang S, Wensman JP, Ferris DP. Locomotor Adaptation by Transtibial Amputees Walking With an Experimental Powered Prosthesis Under Continuous Myoelectric Control. IEEE Trans Neural Syst Rehabil Eng. 2016 May;24(5):573-81. doi: 10.1109/TNSRE.2015.2441061. Epub 2015 Jun 4.

    PMID: 26057851BACKGROUND

Central Study Contacts

Ming Liu, PhD

CONTACT

Noah Rubin, BA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Jackson Family Distinguished Professor

Study Record Dates

First Submitted

July 8, 2022

First Posted

December 26, 2023

Study Start

June 17, 2022

Primary Completion

December 31, 2024

Study Completion

May 31, 2025

Last Updated

December 26, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations